Welcome to the McKesson Proposed Settlement Website
There is a class action lawsuit called New England Carpenters Health Benefits Fund, et al. v. First DataBank, Inc. and McKesson Corporation, Case No. 05-11148-PVS, pending in federal court in Boston, Massachusetts. This lawsuit concerns how brand-name drugs are priced.
Prescription drugs often are priced using certain benchmarks. The most common pricing benchmark is called the Average Wholesale Price ("AWP"). AWP is often used in determining how much insurance companies and other Third-Party Payors will reimburse for these prescription drugs and the co-payment price that some consumers pay for them. The lawsuit claims that two Defendants, McKesson Corporation ("McKesson"), a large drug wholesaler, and First DataBank ("FDB"), a publisher of drug data, wrongfully inflated the mark-up factor used by FDB to determine the AWP for certain prescription drugs ("Subject Drugs"). The lawsuit claims that, as a result, many drug purchasers overpaid for these drugs. Both FDB and McKesson deny any wrongdoing.
|